MedTrace Logo

Korean Red Ginseng and Metabolic Syndrome

NCT00976274 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2012-02-27

Study results available
· View outcomes & findings →

Summary

Five factor consisting of Metabolic syndrome is closely linked by insulin resistance. Until now, several studies have been performed about effects of Korea red ginseng on hypertension, diabetes, and hyperlipidemia, but not metabolic syndrome.

The investigators hypothesize that Korean red ginseng could improve each constituents of metabolic syndrome, arterial stiffness, and inflammatory markers.

The aim of this study is to determine effects of Korean red ginseng on cardiovascular risks in subjects with metabolic syndrome.

Conditions

  • Metabolic Syndrome

Interventions

DIETARY_SUPPLEMENT

Korean red ginseng

5 capsules (300 mg/capsule) three times everyday for 12 weeks

DIETARY_SUPPLEMENT

starch

5 capsules three times everyday for 12 weeks

Sponsors & Collaborators

  • The Korean Society of Ginseng

    lead OTHER

Principal Investigators

  • Jae-Yong Shim, Ph.D. · Yonsei University College of Medicine Gangnam severance Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2011-01-31
Completion
2011-01-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00976274 on ClinicalTrials.gov